Episode Highlights
Scott explains how Rescription's model differs from traditional PBMs
Clarifying misconceptions about the 340B program
Updates on partnerships with Bergen New Bridge and Baton Rouge General
How Rescription addresses pharmaceutical manufacturer pushback
Details on Rescription's patent-pending adjudication technology
Future expansion plans and new service offerings
About this episode
In this episode of Product in Healthtech, we reconnect with Scott Martin, founder and CEO of Rescription, to discover how his company has evolved since our previous conversation.
About Rescription
Rescription, a healthcare startup led by Scott Martin, is disrupting prescription drug affordability through their innovative approach to the 340B federal program. Since launching in 2023, they've achieved 30% savings for health systems while providing zero-dollar copays to patients, and are now expanding to 14 states with their patent-pending adjudication technology.